Physician profile
Veronica Coraci
NPI 1376106823
$2,419.17
in general payments reported to CMS, 2019-2025
15 companies · $1,370 in 2025
The $1,370 reported for 2025 was more than what 93% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $315 · 2024: $734 · 2025: $1,370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,327 · Food and Beverage: $993 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,326.66 |
| Food and Beverage | $992.51 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,165.09 | 2025 | |
| Arthrex, INC. | $302.65 | 2024 | |
| Cgg Medical INC | $255.22 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.43 | 2023 | Jardiance |
| Novo Nordisk INC | $97.13 | 2024 | |
| Pfizer INC. | $89.81 | 2023 | |
| Boston Scientific Corporation | $87.28 | 2023-2024 | Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $83.89 | 2025 | |
| Getinge USA Sales, LLC | $65.00 | 2024 | Vasoview Hemopro 2 |
| Atricure, INC. | $45.43 | 2024 | |
| Solventum Corporation | $37.34 | 2025 | Prevena |
| Davol INC. | $29.59 | 2025 | Progel Applicator Spray Tips |
| E.R. Squibb & Sons, L.L.C. | $26.36 | 2023 | Camzyos, Eliquis |
| Amgen INC. | $22.36 | 2023 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.59 | 2023-2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Coraci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.